
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PRMT5 inhibition disrupts splicing and stemness in glioblastoma
Patty Sachamitr, Jolene Caifeng Ho, Felipe E. Ciamponi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Patty Sachamitr, Jolene Caifeng Ho, Felipe E. Ciamponi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Showing 1-25 of 165 citing articles:
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 404
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 404
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Qin Wu, Matthieu Schapira, C.H. Arrowsmith, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 509-530
Closed Access | Times Cited: 300
Qin Wu, Matthieu Schapira, C.H. Arrowsmith, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 509-530
Closed Access | Times Cited: 300
Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Neural tuning and representational geometry
Nikolaus Kriegeskorte, Xue-Xin Wei
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 11, pp. 703-718
Open Access | Times Cited: 146
Nikolaus Kriegeskorte, Xue-Xin Wei
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 11, pp. 703-718
Open Access | Times Cited: 146
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 118
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 118
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
Qin Wu, Yan Nie, Wail Ba-alawi, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 821-830
Open Access | Times Cited: 90
Qin Wu, Yan Nie, Wail Ba-alawi, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 821-830
Open Access | Times Cited: 90
Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 87
Ryan C. Gimple, Kailin Yang, Matthew Halbert, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 497-514
Closed Access | Times Cited: 87
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
Kavanya Feustel, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2022) Vol. 5, Iss. 3, pp. 58-67
Open Access | Times Cited: 79
Kavanya Feustel, Gerald S. Falchook
Journal of Immunotherapy and Precision Oncology (2022) Vol. 5, Iss. 3, pp. 58-67
Open Access | Times Cited: 79
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 63
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 63
DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 43
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 43
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome
Phoebe C. R. Parrish, James D. Thomas, Austin M. Gabel, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109597-109597
Open Access | Times Cited: 83
Phoebe C. R. Parrish, James D. Thomas, Austin M. Gabel, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109597-109597
Open Access | Times Cited: 83
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Tom Woudenberg, Stéphane Pelleau, François Anna, et al.
EBioMedicine (2021) Vol. 70, pp. 103495-103495
Open Access | Times Cited: 63
Tom Woudenberg, Stéphane Pelleau, François Anna, et al.
EBioMedicine (2021) Vol. 70, pp. 103495-103495
Open Access | Times Cited: 63
Delaying carbon dioxide removal in the European Union puts climate targets at risk
Ángel Galán‐Martín, Daniel Vázquez, Selene Cobo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Ángel Galán‐Martín, Daniel Vázquez, Selene Cobo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 32
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 32
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
Ming Jin, Kwang Won Jeong
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1333-1347
Open Access | Times Cited: 32
Ming Jin, Kwang Won Jeong
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1333-1347
Open Access | Times Cited: 32
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 25
Biomedical Effects of Protein Arginine Methyltransferase Inhibitors
Mengtong Cao, Terry Nguyen, Jiabao Song, et al.
Journal of Biological Chemistry (2025) Vol. 301, Iss. 3, pp. 108201-108201
Open Access | Times Cited: 1
Mengtong Cao, Terry Nguyen, Jiabao Song, et al.
Journal of Biological Chemistry (2025) Vol. 301, Iss. 3, pp. 108201-108201
Open Access | Times Cited: 1
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma
Kinjal Desai, Siyi Wanggou, Erika Luis, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Kinjal Desai, Siyi Wanggou, Erika Luis, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
Hui Liu, Weimin Qiu, Tianyu Sun, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1781-1804
Open Access | Times Cited: 51
Hui Liu, Weimin Qiu, Tianyu Sun, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1781-1804
Open Access | Times Cited: 51
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
Kristen Jensen-Pergakes, John Tatlock, Karen A. Maegley, et al.
Molecular Cancer Therapeutics (2021) Vol. 21, Iss. 1, pp. 3-15
Open Access | Times Cited: 51
Kristen Jensen-Pergakes, John Tatlock, Karen A. Maegley, et al.
Molecular Cancer Therapeutics (2021) Vol. 21, Iss. 1, pp. 3-15
Open Access | Times Cited: 51
Towards a European strategy to address the COVID-19 pandemic
Viola Priesemann, Rudi Balling, Simon Bauer, et al.
The Lancet (2021) Vol. 398, Iss. 10303, pp. 838-839
Open Access | Times Cited: 49
Viola Priesemann, Rudi Balling, Simon Bauer, et al.
The Lancet (2021) Vol. 398, Iss. 10303, pp. 838-839
Open Access | Times Cited: 49
Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms
Yingqing Chen, Xiaomin Shao, Xiangge Zhao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112252-112252
Open Access | Times Cited: 47
Yingqing Chen, Xiaomin Shao, Xiangge Zhao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112252-112252
Open Access | Times Cited: 47
Femtomolar detection of dopamine using surface plasmon resonance sensor based on chitosan/graphene quantum dots thin film
Faten Bashar Kamal Eddin, Yap Wing Fen, Nur Alia Sheh Omar, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 263, pp. 120202-120202
Closed Access | Times Cited: 42
Faten Bashar Kamal Eddin, Yap Wing Fen, Nur Alia Sheh Omar, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 263, pp. 120202-120202
Closed Access | Times Cited: 42
Recent advances in understanding the role of solvated electrons at the plasma-liquid interface of solution-based gas discharges
Daniel T. Elg, Hernan E. Delgado, Daniel C. Martin, et al.
Spectrochimica Acta Part B Atomic Spectroscopy (2021) Vol. 186, pp. 106307-106307
Open Access | Times Cited: 42
Daniel T. Elg, Hernan E. Delgado, Daniel C. Martin, et al.
Spectrochimica Acta Part B Atomic Spectroscopy (2021) Vol. 186, pp. 106307-106307
Open Access | Times Cited: 42